Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units: A Prospective Multicenter National Observational Study (NOSOREA-3)

NCT06392568 is registered in ClinicalTrials.gov with Abderrahmane Mami Hospital as lead sponsor.

NCT NCT06392568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06392568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units: A Prospective Multicenter National Observational Study (NOSOREA-3)
Lead sponsor
Abderrahmane Mami Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2024
Completion date
May 31, 2024
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carbapenem resistant bacterial infection, critical illness, cross infection, vancomycin-resistant enterococcal infection